Prices as of 2026/10/30 close
Company comparison · Material Handling & Pneumatics
Tsubaki is the bigger company, with revenue of ¥295.9B — 1.9x CKD's ¥157.9B.
CKD earns more on each yen of sales, with an operating margin of 12.4% — 5.1 points above Tsubaki (7.3%).
Revenue growth in the latest results: Tsubaki +6.0%, CKD +1.4%. For next year, CKD guides for the fastest operating profit growth (+24.7%).
CKD pays more on average — ¥7.31M against ¥6.99M at Tsubaki.
Over the past year the shares moved CKD +42.5%, Tsubaki +23.0%.
Head-to-head wins17 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
Tsubaki aheadTsubaki 3 : CKD 0
Revenue: Tsubaki ¥295.9B / CKD ¥157.9B
ProfitabilityInvestors
Tsubaki aheadTsubaki 3 : CKD 1
Operating margin: Tsubaki 7.3% / CKD 12.4%
GrowthInvestors
EvenTsubaki 2 : CKD 2
Revenue growth (YoY): Tsubaki +6.0% / CKD +1.4%
Stock & balance sheetInvestors
CKD aheadTsubaki 1 : CKD 2
Share price, 1 year: Tsubaki +23.0% / CKD +42.5%
Pay & workforceJob seekers
CKD aheadTsubaki 1 : CKD 2
Average salary: Tsubaki ¥6.99M / CKD ¥7.31M
| Metric | Tsubaki | CKD | Gap |
|---|---|---|---|
| Revenue | ◎¥295.9B | ¥157.9B | 1.9x |
| Operating profit | ◎¥21.6B | ¥19.6B | 1.1x |
| Net income | ◎¥29.7B | ¥13.6B | 2.2x |
| Metric | Tsubaki | CKD | Gap |
|---|---|---|---|
| Operating margin | 7.3% | ◎12.4% | 5.1pt |
| Net margin | ◎10.0% | 8.6% | 1.4pt |
| ROE | ◎10.7% | 9.4% | 1.3pt |
| Revenue per employee | ◎¥95M | ¥66M | 1.4x |
| Metric | Tsubaki | CKD | Gap |
|---|---|---|---|
| Revenue growth (YoY) | ◎+6.0% | +1.4% | 4.6pt |
| Operating profit growth (YoY) | −5.6% | ◎+3.3% | 8.9pt |
| Guidance: revenue growthnext FY plan | ◎+18.3% | +14.0% | 4.3pt |
| Guidance: op. profit growthnext FY plan | +18.2% | ◎+24.7% | 6.6pt |
| Metric | Tsubaki | CKD | Gap |
|---|---|---|---|
| Share price, 1 year | +23.0% | ◎+42.5% | 19.5pt |
| Share price, 3 months | ◎+0.8% | −11.5% | 12.3pt |
| P/E (trailing)lower = cheaper | 9.0x | 22.9x | |
| Equity ratio | 66.1% | ◎67.7% | 1.6pt |
| Share price (close) | ¥2,665 | ¥4,645 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | Tsubaki | CKD | Gap |
|---|---|---|---|
| Average salary | ¥6.99M | ◎¥7.31M | ¥0.33M |
| Starting salary (monthly) | ◎¥273,000 | ¥252,000 | ¥21,000 |
| Average tenure | 16.5 yrs | ◎16.7 yrs | 0.2 |
| Average age | 43.5 | 41.5 | 2.0 |
| Employees | 3,126 | 2,389 | 1.3x |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥2,665+23.0% (1Y)
Tsubaki +23.0% over 1Y. Compared: CKD +42.5%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
Tsubaki5 segments
CKD2 segments
AAverage annual salary from the securities filings: CKD ¥7.31M, Tsubaki ¥6.99M. CKD pays the most. Averages also depend on staff age and job mix, so check the average age too (Tsubaki 43.5, CKD 41.5).
ARevenue in the latest results: Tsubaki ¥295.9B, CKD ¥157.9B. Tsubaki is the bigger company, with revenue of ¥295.9B — 1.9x CKD's ¥157.9B.
AOperating margins: CKD 12.4%, Tsubaki 7.3%. CKD turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): CKD +42.5%, Tsubaki +23.0%. CKD has risen the most.
Comparing 2 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.
